The cross-sectional GRAS sample: A comprehensive phenotypical data collection of schizophrenic patients

BMC Psychiatry

Volumn 10, Issue , 2010, Pages

  Ribbe, Katja ^a   Friedrichs, Heidi ^a   Begemann, Martin ^a   Grube, Sabrina ^a   Papiol, Sergi ^a,y   Kästner, Anne ^a   Gerchen, Martin F ^a   Ackermann, Verena ^a   Tarami, Asieh ^a   Treitz, Annika ^a   Flögel, Marlene ^a   Adler, Lothar ^b   Aldenhoff, Josef B ^c   Becker Emner, Marianne ^d   Becker, Thomas ^e   Czernik, Adelheid ^f   Dose, Matthias ^g   Folkerts, Here ^h   Freese, Roland ⁱ   Günther, Rolf ^j   Herpertz, Sabine ^k   Hesse, Dirk ^l   Kruse, Gunther ^m   Kunze, Heinrich ⁿ   Franz, Michael ⁿ   Löhrer, Frank ^o   Maier, Wolfgang ^p   Mielke, Andreas ^j   Müller Isberner, Rüdiger ^q   Oestereich, Cornelia ^r   Pajonk, Frank Gerald ^s   Pollmächer, Thomas ^t   Schneider, Udo ^u   Schwarz, Hans Joachim ^c   Kröner Herwig, Birgit ^v   Havemann Reinecke, Ursula ^w,y   Frahm, Jens ^x,y,z   Stühmer, Walter ^a,y,z   Falkai, Peter ^w,y,z   Brose, Nils ^a,y,z   Nave, Klaus Armin ^a,y,z   Ehrenreich, Hannelore ^a,y,z   more..

^a MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^b Ecumenical Hospital Hainich   (Germany)

^c Hospital of Psychiatry and Psychotherapy   (Germany)

^d Psychiatric Federation Oldenburger Land   (Germany)

^e UNIVERSITY OF ULM   (Germany)

^f KLINIKUM FULDA   (Germany)

^g Isar Amper Hospital   (Germany)

^h Reinhard Nieter Krankenhaus Stadtische Kliniken gGmbH   (Germany)

ⁱ Vitos Hospital of Forensic Psychiatry Eltville   (Germany)

^j Vitos Hospital of Psychiatry and Psychotherapy Merxhausen   (Germany)

^k UNIVERSITY OF ROSTOCK   (Germany)

^l Hospital of Forensic Psychiatry   (Germany)

^m Regional Hospitals Hannover   (Germany)

ⁿ Vitos Hospital of Psychiatry and Psychotherapy   (Germany)

^o Addiction Hospital Am Waldsee   (Germany)

^p UNIVERSITY HOSPITAL BONN   (Germany)

^q Vitos Haina Forensic Psychiatric Hospital   (Germany)

^r Regional Hospitals Hannover   (Germany)

^s Dr K Fontheim's Hospital for Mental Health   (Germany)

^t Hospital Ingolstadt   (Germany)

^u Lübbecke Hospital   (Germany)

^v UNIVERSITY OF GÖTTINGEN   (Germany)

^w UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^x Biomedizinische NMR Forschungs GmbH   (Germany)

^y DFG Research Center for the Molecular Physiology of the Brain CMPB   (Germany)

^z GRAS Initiative ^*  (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; NEUROLEPTIC AGENT;

ADULT; AGED; AKATHISIA; AMENORRHEA; ARTICLE; COGNITION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSKINESIA; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; GENETIC ASSOCIATION; GERMANY; GYNECOMASTIA; HOSPITAL DISCHARGE; HUMAN; HYPERHIDROSIS; HYPERPROLACTINEMIA; HYPERSALIVATION; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MEDICAL RESEARCH; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; PARKINSONISM; PHENOTYPE; SCHIZOPHRENIA; SEXUAL DYSFUNCTION; SKIN DISEASE; TACHYCARDIA; URINE RETENTION; VERTIGO; VISUAL DISORDER; WORKING MEMORY; XEROSTOMIA; ADOLESCENT; CHEMICALLY INDUCED DISORDER; COGNITIVE DEFECT; COMPARATIVE STUDY; EXTRAPYRAMIDAL SYNDROME; GENETIC DATABASE; GENETICS; INFORMATION PROCESSING; METHODOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL ASPECT; PSYCHOLOGY; STATISTICS;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; DATA COLLECTION; DATABASES, GENETIC; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PHENOTYPE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 78149249353     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-10-91     Document Type: Article

References (84)

1. Jablensky A, Sartorius N, Ernberg G, Anker M, Korten A, Cooper JE, Day R, Bertelsen A. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med Monogr Suppl 1992, 20:1-97. 10.1017/S0264180100000904, 1565705.
2. American Psychiatric Association Diagnostic and statistical manual of mental disorders, (DSM-IV) 1994, Washington, DC: American Psychiatric Press, 4, American Psychiatric Association.
3. World Health Organization The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines 1992, Geneva: WHO, World Health Organization.
4. Cardno AG, Gottesman II. Twin studies of schizophrenia: from bow-and-arrow concordances to starwars Mx and functional genomics. Am J Med Genet 2000, 97(1):12-17. 10.1002/(SICI)1096-8628(200021)97:1<12::AID-AJMG3>3.0.CO;2-U, 10813800.
5. Lichtenstein P, Yip BH, Björk C, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. The Lancet 2009, 373(9659):234-239.
6. Franzek E, Beckmann H. Different Genetic Background of Schizophrenia Spectrum Psychoses: A Twin Study. Am J Psychiatry 1998, 155(1):76-83.
7. Cardno AG, Marshall EJ, Coid B, Macdonald AM, Ribchester TR, Davies NJ, Venturi P, Jones LA, Lewis SW, Sham PC, Gottesman II, Farmer AE, McGuffin P, Reveley AM, Murray RM. Heritability Estimates for Psychotic Disorders: The Maudsley Twin Psychosis Series. Arch Gen Psychiatry 1999, 56(2):162-168. 10.1001/archpsyc.56.2.162, 10025441.
8. Gottesman I, Shields J. A polygenic theory of schizophrenia. Proc Natl Acad Sci USA 1967, 58(1):199-205. 10.1073/pnas.58.1.199, 335617, 5231600.
9. Riley B, Asherson PJ, McGuffin P. Genetics and schizophrenia. Schizophrenia 2003, Massachusetts: Blackwell Publishing, Hirsch SR, Weinberger DR.
10. Duan J, Sanders AR, Gejman PV. Genome-wide approaches to schizophrenia. Brain Research Bulletin
11. Begemann M, Grube S, Papiol S, Malzahn D, Krampe H, Ribbe K, Friedrichs H, Radyushkin KA, El-Kordi A, Benseler F, Hannke K, Sperling S, Schwerdtfeger D, Thanhauser I, Gerchen MF, Ghorbani M, Gutwinski S, Hilmes C, Leppert R, Ronnenberg A, Sowislo J, Stawicki S, Stodtke M, Szuszies C, Reim K, Riggert J, Eckstein F, Falkai P, Bickeboller H, Nave KA, et al. Modification of cognitive performance in schizophrenia by complexin 2 gene polymorphisms. Arch Gen Psychiatry 2010, 67(9):879-888. 10.1001/archgenpsychiatry.2010.107, 20819981.
12. Häfner H, Maurer K, Löffler W, an der Heiden W, Munk-Jørgensen P, Hambrecht M, Riecher-Rössler A. The ABC schizophrenia study: a preliminary overview of the results. Social Psychiatry and Psychiatric Epidemiology 1998, 33(8):380-386. 10.1007/s001270050069, 9708025.
13. Jablensky A, McGrath J, Herrman H, Castle D, Gureje O, Evans M, Carr V, Morgan V, Korten A, Harvey C. Psychotic disorders in urban areas: an overview of the Study on Low Prevalence Disorders. Aust N Z J Psychiatry 2000, 34(2):221-236.
14. Haro JM, Edgell ET, Jones PB, Alonso J, Gavart S, Gregor KJ, Wright P, Knapp M. The European Schizophrenia Outpatient Health Outcomes (SOHO) study: rationale, methods and recruitment. Acta Psychiatr Scand 2003, 107(3):222-232. 10.1034/j.1600-0447.2003.00064.x, 12580830.
15. Karayiorgou M, Torrington M, Abecasis GR, Pretorius H, Robertson B, Kaliski S, Lay S, Sobin C, Möller N, Lundy SL, Blundell ML, Gogos JA, Roos JL. Phenotypic characterization and genealogical tracing in an Afrikaner schizophrenia database. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2004, 124B(1):20-28.
16. Fleischhacker WW, Keet IP, Kahn RS. The European First Episode Schizophrenia Trial (EUFEST): rationale and de sign of the trial. Schizophr Res 2005, 78(2-3):147-156. 10.1016/j.schres.2005.06.004, 16055308.
17. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005, 353(12):1209-1223. 10.1056/NEJMoa051688, 16172203.
18. Price GW, Michie PT, Johnston J, Innes-Brown H, Kent A, Clissa P, Jablensky AV. A Multivariate Electrophy siological Endophenotype, from a Unitary Cohort, Shows Greater Research Utility than Any Single Feature in the Western Australian Family Study of Schizophrenia. Biological Psychiatry 2006, 60(1):1-10. 10.1016/j.biopsych.2005.09.010, 16368076.
19. Calkins ME, Dobie DJ, Cadenhead KS, Olincy A, Freedman R, Green MF, Greenwood TA, Gur RE, Gur RC, Light GA, Mintz J, Nuechterlein KH, Radant AD, Schork NJ, Seidman LJ, Siever LJ, Silverman JM, Stone WS, Swerdlow NR, Tsuang DW, Tsuang MT, Turetsky BI, Braff DL. The Consortium on the Genetics of Endophenotypes in Schizophrenia: Model Recruitment, Assessment, and Endophenotyping Methods for a Multisite Collaboration. Schizophr Bull 2007, 33(1):33-48. 10.1093/schbul/sbl044, 2632302, 17035358.
20. Allen NC, Bagade S, McQueen MB, Ioannidis JPA, Kavvoura FK, Khoury MJ, Tanzi RE, Bertram L. Systematic meta-analy ses and field synopsis of genetic association studies in schizophrenia: the SzGene database. Nat Genet 2008, 40(7):827-834. 10.1038/ng.171, 18583979.
21. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 2003, 29(1):15-31.
22. Poyastro Pinheiro A, Keefe RSE, Skelly T, Olarte M, Leviel K, Lange LA, Lange EM, Scott Stroup T, Lieberman J, Sullivan PF. AKT1 and neurocognition in schizophrenia. Australian and New Zealand Journal of Psychiatry 2009, 41(2):169-177.
23. Sullivan PF, Keefe RSE, Lange LA, Lange EM, Stroup TS, Lieberman J, Maness PF. NCAM1 and Neurocognition in Schizophrenia. Biological Psychiatry 2007, 61(7):902-910. 10.1016/j.biopsych.2006.07.036, 17161382.
24. Crowley JJ, Keefe RSE, Perkins DO, Stroup TS, Lieberman JA, Sullivan PF. The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 2008, 147B(7):1298-1300.
25. Sullivan PF, Lin D, Tzeng JY, van den Oord E, Perkins D, Stroup TS, Wagner M, Lee S, Wright FA, Zou F, Liu W, Downing AM, Lieberman J, Close SL. Genomewide association for schizophrenia in the CATIE study: results of stage 1. Mol Psychiatry 2008, 13(6):570-584. 10.1038/mp.2008.25, 18347602.
26. Australian Schizophrenia Research Bank. , http://www.schizophreniaresearch.org.au/bank/index.php
27. Loughland CM, Carr VJ, Lewin TJ. The NISAD Schizophrenia Research Register: why do we need a database of schizophrenia volunteers?. Aust N Z J Psychiatry 2001, 35(5):660-667. 10.1080/0004867010060516, 11551283.
28. Loughland C, Draganic D, McCabe K, Richards J, Nasir A, Allen J, Catts S, Jablensky A, Henskens F, Michie P, Mowry B, Pantelis C, Schall U, Rodney S, Tooney P, Carr V. The Australian Schizophrenia Research Bank: A database of comprehensive clinical, endophenotypic and genetic data for etiological studies of schizophrenia. Australian and New Zealand Journal of Psychiatry
29. Wittchen H-U, Zaudig M, Fydrich T. SKID-I (Strukturiertes Klinisches Interview für DSM-IV; Achse I: Psychische Störungen) 1997, Göttingen: Hogrefe.
30. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276.
31. Guy W. Clinical Global Impression (CGI). ECDEU Assessment manual for psychopharmacology, revised National Institue of Mental Health. Rockville, MD 1976,
32. Laux L, Glanzmann P, Schaffner P, Spielberger CD. Das State-Trait-Angstinventar (STAI) 1981, Weinheim: Beltz.
33. Franke GH. Brief Symptom Inventory (BSI) 2000, Goettingen: Beltz.
34. Kupfer J, Brosig B, Braehler E. Toronto Alexithymie-Skala-26 (TAS-26) 2001, Goettingen: Hogrefe.
35. Lehrl S, Triebig G, Fischer B. Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand 1995, 91(5):335-345. 10.1111/j.1600-0404.1995.tb07018.x, 7639062.
36. Lehrl S. Mehrfach-Wortschatz-Intelligenztest MWT-B 1999, Balingen: Spitta Verlag.
37. Horn W. Leistungsprüfsystem (LPS) 1983, Goettingen: Hogrefe, 2.
38. Gold JM, Carpenter C, Randolph C, Goldberg TE, Weinberger DR. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch Gen Psychiatry 1997, 54(2):159-165.
39. Chapman RL. The MacQuarrie test for mechanical ability. Psychometrika 1948, 13(3):175-179. 10.1007/BF02289259, 18885736.
40. War-Department Army Individual Test Battery. Manual of directions and scoring 1944, Washington, D.C.: War Department, Adjutant General's Office, War-Department.
41. Perianez JA, Rios-Lago M, Rodriguez-Sanchez JM, Adrover-Roig D, Sanchez-Cubillo I, Crespo-Facorro B, Quemada JI, Barcelo F. Trail Making Test in traumatic brain injury, schizophrenia, and normal ageing: sample comparisons and normative data. Arch Clin Neuropsychol 2007, 22(4):433-447. 10.1016/j.acn.2007.01.022, 17336493.
42. Kessler J, Denzler P, Markowitsch HJ. Demenz-Test (DT) 1999, Göttingen: Hogrefe.
43. Aschenbrenner S, Tucha O, Lange KW. Der Regensburger Wortflüssigkeits-Test (RWT) 2000, Göttingen: Hogrefe.
44. Tewes U. Hamburg-Wechsler Intelligenztest fuer Erwachsene (HAWIE-R) 1991, Bern: Huber.
45. Helmstaedter C, Lendt M, Lux S. Verbaler Lern- und Merkfähigkeitstest (VLMT) 2001, Goettingen: Beltz.
46. Zimmermann P, Fimm B. Testbatterie zur Aufmerksamkeitsprüfung (TAP). Version 1.02c 1993, Herzogenrath: PSYTEST.
47. Chen EY, Shapleske J, Luque R, McKenna PJ, Hodges JR, Calloway SP, Hymas NF, Dening TR, Berrios GE. The Cambridge Neurological Inventory: a clinical instrument for assessment of soft neurological signs in psychiatric patients. Psychiatry Res 1995, 56(2):183-204. 10.1016/0165-1781(95)02535-2, 7667443.
48. Bartels C, Mertens N, Hofer S, Merboldt KD, Dietrich J, Frahm J, Ehrenreich H. Callosal dysfunction in amyotrophic lateral sclerosis correlates with diffusion tensor imaging of the central motor system. Neuromuscul Disord 2008, 18(5):398-407. 10.1016/j.nmd.2008.02.005, 18456495.
49. Barnes TR. The Barnes Akathisia Rating Scale - revisited. J Psychopharmacol 2003, 17(4):365-370. 10.1177/0269881103174013, 14870947.
50. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970, 212:11-19. 10.1111/j.1600-0447.1970.tb02066.x, 4917967.
51. Simpson GM, Lee JH, Zoubok B, Gardos G. A rating scale for tardive dyskinesia. Psychopharmacology (Berl) 1979, 64(2):171-179. 10.1007/BF00496058, 115037.
52. Guy W. Abnormal involuntary movement scale (AIMS). ECDEU Assessment manual for psychopharmacology, revised National Institute of Mental Health. Rockville, MD 1976,
53. Krampe H, Bartels C, Victorson D, Enders CK, Beaumont J, Cella D, Ehrenreich H. The influence of personality factors on disease progression and health-related quality of life in people with ALS. Amyotroph Lateral Scler 2008, 9(2):99-107. 10.1080/17482960701875805, 18428002.
54. SPSS Inc. , http://www.spss.com/
55. Blom G. Statistical Estimates and Transformed Beta Variables 1958, New York: John Wiley and Sons, Inc.
56. Davis JM. Comparative doses and costs of antipsychotic medication. Arch Gen Psychiatry 1976, 33(7):858-861.
57. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989, 154:672-676. 10.1192/bjp.154.5.672, 2574607.
58. Loughland CM, Carr VJ, Lewin TJ, Barnard RE, Chapman JL, Walton JM. Potential sampling and recruitment source impacts in schizophrenia research. Psychiatry Res 2004, 125(2):117-127. 10.1016/j.psychres.2003.11.002, 15006435.
59. Aleman A, Kahn RS, Selten J-P. Sex differences in the risk of schizophrenia: evidence from meta-analysis. Arch Gen Psychiatry 2003, 60(6):565-571. 10.1001/archpsyc.60.6.565, 12796219.
60. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev 2008, 30:67-76. 10.1093/epirev/mxn001, 18480098.
61. Riecher-Rossler A, Hafner H. Gender aspects in schizophrenia: bridging the border between social and biological psychiatry. Acta Psychiatr Scand Suppl 2000, (407):58-62. 10.1034/j.1600-0447.2000.00011.x, 11261642.
62. Henry J-M, Boyer L, Belzeaux R, Baumstarck-Barrau K, Samuelian J-C. Mental Disorders Among Homeless People Admitted to a French Psychiatric Emergency Service. Psychiatr Serv 2010, 61(3):264-271. 10.1176/appi.ps.61.3.264, 20194403.
63. Toro PA, Bellavia CW, Daeschler CV, Owens BJ, Wall DD, Passero JM, Thomas DM. Distinguishing homelessness from poverty: A comparative study. Journal of Consulting and Clinical Psychology 1995, 63(2):280-289. 10.1037/0022-006X.63.2.280, 7751489.
64. Israel N, Toro P, Ouellette N. Changes in the Composition of the Homeless Population: 1992-2002. American Journal of Community Psychology 2010, 46(1-2):49-59. 10.1007/s10464-010-9326-9, 20524149.
65. Kraepelin E. Psychiatrie. Ein Lehrbuch für Studierende und Ärzte. Sechste, vollständig umgearbeitete Auflage 1899, Leipzig: Johann Ambrosius Barth.
66. Castle DJ, Sham PC, Wessely S, Murray RM. The subtyping of schizophrenia in men and women: a latent class analysis. Psychol Med 1994, 24(1):41-51. 10.1017/S0033291700026817, 8208893.
67. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl 2000, 401:3-38. 10.1111/j.0065-1591.2000.0ap25.x, 10887978.
68. Larsen TK, McGlashan TH, Johannessen JO, Vibe-Hansen L. First-episode schizophrenia: II. Premorbid patterns by gender. Schizophr Bull 1996, 22(2):257-269.
69. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990, 16(2):185-194.
70. Häfner H. Onset and early course as determinants of the further course of schizophrenia. Acta Psychiatr Scand Suppl 2000, (407):44-48. 10.1034/j.1600-0447.2000.00008.x, 11261639.
71. Moriarty PJ, Lieber D, Bennett A, White L, Parrella M, Harvey PD, Davis KL. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophr Bull 2001, 27(1):103-113.
72. Thorup A, Petersen L, Jeppesen P, Ohlenschlaeger J, Christensen T, Krarup G, Jorgensen P, Nordentoft M. Gender differences in young adults with first-episode schizophrenia spectrum disorders at baseline in the Danish OPUS study. Nerv Ment Dis 2007, 195(5):396-405.
73. Weiser M, Reichenberg A, Rabinowitz J, Kaplan Z, Mark M, Nahon D, Davidson M. Gender differences in premorbid cognitive performance in a national cohort of schizophrenic patients. Schizophr Res 2000, 45(3):185-190. 10.1016/S0920-9964(99)00190-5, 11042436.
74. Green RE, Melo B, Christensen B, Ngo LA, Monette G, Bradbury C. Measuring premorbid IQ in traumatic brain injury: an examination of the validity of the Wechsler Test of Adult Reading (WTAR). J Clin Exp Neuropsychol 2008, 30(2):163-172. 10.1080/13803390701300524, 18213530.
75. Aylward E, Walker E, Bettes B. Intelligence in schizophrenia: meta-analysis of the research. Schizophr Bull 1984, 10(3):430-459.
76. Kern RS, Nuechterlein KH, Green MF, Baade LE, Fenton WS, Gold JM, Keefe RS, Mesholam-Gately R, Mintz J, Seidman LJ, Stover E, Marder SR. The MATRICS Consensus Cognitive Battery, part 2: co-norming and standardization. Am J Psychiatry 2008, 165(2):214-220. 10.1176/appi.ajp.2007.07010043, 18172018.
77. Hoff AL, Wieneke M, Faustman WO, Horon R, Sakuma M, Blankfeld H, Espinoza S, DeLisi LE. Sex differences in neurops ychological functioning of first-episode and chronically ill schizophrenic patients. Am J Psychiatry 1998, 155(10):1437-1439.
78. Seeman MV. Gender differences in the prescribing of antipsychotic drugs. Am J Psychiatry 2004, 161(8):1324-1333. 10.1176/appi.ajp.161.8.1324, 15285956.
79. Seeman MV. Secondary effects of antipsychotics: women at greater risk than men. Schizophr Bull 2009, 35(5):937-948. 10.1093/schbul/sbn023, 2728808, 18400811.
80. Dominguez Mde G, Viechtbauer W, Simons CJ, van Os J, Krabbendam L. Are psychotic psychopathology and neurocognition orthogonal? A systematic review of their associations. Psychol Bull 2009, 135(1):157-171. 10.1037/a0014415, 19210058.
81. Puig O, Penades R, Gasto C, Catalan R, Torres A, Salamero M. Verbal memory, negative symptomatology and prediction psychosocial functioning in schizophrenia. Psychiatry Res 2008, 158(1):11-17. 10.1016/j.psychres.2007.04.017, 18001844.
82. Schennach-Wolff R, Jager M, Seemuller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Huff W, Heuser I, Maier W, Lemke MR, Ruther E, Buchkremer G, Gastpar M, Moller HJ, Riedel M. Defining and predicting functional outcome in schizophrenia and schizophrenia spectrum disorders. Schizophr Res 2009, 113(2-3):210-217. 10.1016/j.schres.2009.05.032, 19560901.
83. Gaite L, Vazquez-Barquero JL, Herran A, Thornicroft G, Becker T, Sierra-Biddle D, Ruggeri M, Schene A, Knapp M, Vazquez-Bourgon J. Main determinants of Global Assessment of Functioning score in schizophrenia: a European multicenter study. Compr Psychiatry 2005, 46(6):440-446. 10.1016/j.comppsych.2005.03.006, 16275211.
84. Ehrenreich H, Siren AL. Neuroprotection--what does it mean?--What means do w e have?. Eur Arch Psychiatry Clin Neurosci 2001, 251(4):149-151. 10.1007/s004060170034, 11697578.